loanDepot Inc President Jeff Walsh Sells 82,141 Shares
On January 9, 2024, Jeff Walsh, President of LDI Mortgage, executed a sale of 82,141 shares of loanDepot Inc (NYSE:LDI), as reported in a recent SEC Filing. loanDepot Inc, operating in the financial sector, is a retail mortgage lender that originates, underwrites, and sells mortgage loans and refinances. The company's services include conventional and government-backed loans, as well as home equity and personal loans.
Over the past year, the insider has sold a total of 971,283 shares and has not made any purchases. The recent transaction is part of a series of sales by the insider, indicating a consistent pattern of share disposals over the period.
The insider transaction history for loanDepot Inc shows a trend of more insider sales than purchases over the past year, with 4 insider buys and 68 insider sells recorded.
On the day of the insider's recent sale, shares of loanDepot Inc were trading at $3.02, giving the company a market capitalization of $505.394 million.
The stock's price-to-GF-Value ratio stands at 2.5, with a current trading price of $3.02 and a GuruFocus Value of $1.21. This ratio suggests that loanDepot Inc is Significantly Overvalued according to its GF Value.
The GF Value is determined by considering historical trading multiples such as price-earnings ratio, price-sales ratio, price-book ratio, and price-to-free cash flow, along with a GuruFocus adjustment factor based on the company's historical returns and growth, and future business performance estimates provided by Morningstar analysts.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
This article first appeared on GuruFocus.
